Resources

Resources

Navigating the Medicare Drug Price Negotiation Landscape

February 25, 2025 at 1PM EST

The Medicare drug price negotiation component of the Inflation Reduction Act represents a watershed moment for pharmaceutical pricing in the U.S., with far-reaching implications for drug development, market access, and industry strategy. The implications of this program are reshaping investment decisions and impacting pricing and market access strategies for new and existing drugs. The pharmaceutical industry is actively adapting its approach to portfolio management and market access planning in response to this evolving landscape. Join us as we explore recent developments in this space and review considerations for manufacturers:

In this webinar, we will delve into the key aspects of the IRA, including:

    • A First Look at IPAY 2027: We will examine the initial set of drugs selected for Medicare price negotiation in 2027, analyzing the potential impact on the pharmaceutical industry.
    • Strategic Considerations for Manufacturers: This session will explore key strategic considerations for pharmaceutical companies navigating the complexities of Medicare price negotiations, including portfolio management, pricing strategies, and market access planning.
    • Stakeholder Impact: We will examine how these negotiations may impact key stakeholders, such as payers and retail pharmacies, within the evolving healthcare ecosystem.
    • The Road Ahead: We will discuss the market access and pricing implications of Medicare drug price negotiation over the next several years, providing valuable insights for industry leaders.

    Join us for this timely and informative webinar as we navigate the challenges and opportunities presented by this transformative legislation.


    Bharat Lakshminarayanan
    Executive Director, Advisory Services

    Jeff Baab
    Partner, Advisory Services

    adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article